Frontiers in Oncology (Aug 2022)
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma
- Lekshmi R. Nath,
- Mundanattu Swetha,
- Vinod Vijayakurup,
- Arun Kumar Thangarasu,
- Arun Kumar Thangarasu,
- Nair Hariprasad Haritha,
- Anwar Shabna,
- Sreekumar U. Aiswarya,
- Sreekumar U. Aiswarya,
- Tennyson P. Rayginia,
- C. K. Keerthana,
- Kalishwaralal Kalimuthu,
- Sankar Sundaram,
- Ravi Shankar Lankalapalli,
- Ravi Shankar Lankalapalli,
- Sreekumar Pillai,
- Rheal Towner,
- Noah Isakov,
- Ruby John Anto
Affiliations
- Lekshmi R. Nath
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Mundanattu Swetha
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Vinod Vijayakurup
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Arun Kumar Thangarasu
- Chemical Sciences and Technology Division, Council for Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram, India
- Arun Kumar Thangarasu
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India
- Nair Hariprasad Haritha
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Anwar Shabna
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Sreekumar U. Aiswarya
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Sreekumar U. Aiswarya
- Department of Biotechnology, University of Calicut, Malappuram, India
- Tennyson P. Rayginia
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- C. K. Keerthana
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Kalishwaralal Kalimuthu
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- Sankar Sundaram
- Department of Pathology, Government Medical College, Kottayam, India
- Ravi Shankar Lankalapalli
- Chemical Sciences and Technology Division, Council for Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram, India
- Ravi Shankar Lankalapalli
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India
- Sreekumar Pillai
- Department of Surgical Oncology, Jubilee Mission Medical College and Research Institute, Thrissur, India
- Rheal Towner
- Department of Pathology and Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma, United States
- Noah Isakov
- The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer Sheva, Israel
- Ruby John Anto
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
- DOI
- https://doi.org/10.3389/fonc.2022.991401
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords